loading
Voyager Therapeutics Inc stock is traded at $3.43, with a volume of 611.73K. It is up +2.08% in the last 24 hours and up +8.54% over the past month. Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
See More
Previous Close:
$3.36
Open:
$3.38
24h Volume:
611.73K
Relative Volume:
0.82
Market Cap:
$190.26M
Revenue:
$163.78M
Net Income/Loss:
$25.88M
P/E Ratio:
5.2769
EPS:
0.65
Net Cash Flow:
$-28.66M
1W Performance:
-8.04%
1M Performance:
+8.54%
6M Performance:
-18.72%
1Y Performance:
-48.58%
1-Day Range:
Value
$3.35
$3.53
1-Week Range:
Value
$3.275
$3.90
52-Week Range:
Value
$2.645
$8.275

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Name
Name
Voyager Therapeutics Inc
Name
Phone
857-259-5340
Name
Address
75 HAYDEN AVENUE, LEXINGTON, MA
Name
Employee
172
Name
Twitter
@VoyagerTx
Name
Next Earnings Date
2025-03-11
Name
Latest SEC Filings
Name
VYGR's Discussions on Twitter

Compare VYGR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
VYGR
Voyager Therapeutics Inc
3.43 213.00M 163.78M 25.88M -28.66M 0.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-10-25 Initiated Cantor Fitzgerald Overweight
Dec-02-24 Initiated Citigroup Buy
Nov-29-24 Resumed Wedbush Outperform
Oct-16-24 Initiated Leerink Partners Outperform
Mar-26-24 Initiated Guggenheim Buy
Mar-19-24 Initiated H.C. Wainwright Buy
Mar-07-24 Initiated Citigroup Buy
Jan-02-24 Upgrade Wells Fargo Equal Weight → Overweight
May-10-23 Initiated Truist Buy
Mar-10-23 Initiated Oppenheimer Outperform
Oct-07-21 Upgrade Robert W. Baird Neutral → Outperform
Feb-26-21 Downgrade Robert W. Baird Outperform → Neutral
Feb-03-21 Downgrade BTIG Research Buy → Neutral
Feb-03-21 Downgrade Wedbush Outperform → Neutral
Dec-24-20 Downgrade Cantor Fitzgerald Overweight → Neutral
Dec-23-20 Downgrade Raymond James Outperform → Mkt Perform
Nov-11-20 Downgrade Oppenheimer Outperform → Perform
Nov-10-20 Downgrade Raymond James Strong Buy → Outperform
Nov-10-20 Downgrade Wells Fargo Overweight → Equal Weight
Mar-19-20 Initiated The Benchmark Company Buy
Feb-06-20 Initiated Oppenheimer Outperform
Nov-15-18 Upgrade Raymond James Outperform → Strong Buy
Sep-10-18 Resumed BTIG Research Buy
Sep-10-18 Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-04-18 Initiated H.C. Wainwright Buy
Mar-12-18 Downgrade Evercore ISI Outperform → In-line
Mar-12-18 Downgrade Wedbush Outperform → Neutral
Feb-02-18 Initiated Morgan Stanley Overweight
Nov-28-17 Resumed Piper Jaffray Overweight
Oct-31-17 Initiated Robert W. Baird Outperform
Oct-27-17 Initiated Canaccord Genuity Buy
Oct-23-17 Reiterated Stifel Buy
Oct-12-17 Initiated Raymond James Outperform
Aug-17-17 Initiated Evercore ISI Outperform
Jul-28-17 Resumed Stifel Buy
View All

Voyager Therapeutics Inc Stock (VYGR) Latest News

pulisher
Aug 20, 2025

Trend Reversal Possible in Voyager Therapeutics Inc. Charts IndicateJuly 2025 Big Picture & Fast Exit/Entry Strategy Plans - beatles.ru

Aug 20, 2025
pulisher
Aug 20, 2025

Is Voyager Therapeutics Inc. the Top Chart Pick This WeekLayoff News & Risk Managed Trade Strategies - newsyoung.net

Aug 20, 2025
pulisher
Aug 20, 2025

Voyager Therapeutics Inc. Price Holds Above Key Fib LevelGold Moves & Low Drawdown Investment Ideas - beatles.ru

Aug 20, 2025
pulisher
Aug 19, 2025

Analysts Spot Bullish Divergence in Voyager Therapeutics Inc.Quarterly Profit Report & Entry Point Confirmation Signals - thegnnews.com

Aug 19, 2025
pulisher
Aug 17, 2025

What makes Voyager Therapeutics Inc. stock price move sharply2025 Key Highlights & Safe Capital Growth Stock Tips - thegnnews.com

Aug 17, 2025
pulisher
Aug 16, 2025

Can Voyager Therapeutics Inc. Bounce Back From Weekly LowPortfolio Update Summary & Step-by-Step Swing Trade Plans - kangso.co.kr

Aug 16, 2025
pulisher
Aug 16, 2025

Technical Charts Suggest Momentum Shift in Voyager Therapeutics Inc.Bull Run & Community Consensus Stock Picks - sundaytimes.kr

Aug 16, 2025
pulisher
Aug 15, 2025

Voyager Therapeutics: Strategic Positioning and Promising Pipeline Drive Buy Rating - AInvest

Aug 15, 2025
pulisher
Aug 14, 2025

Chart Analysts Warn of Resistance Near Voyager Therapeutics Inc. PriceMarket Trend Summary & Stepwise Trade Signal Guides - sundaytimes.kr

Aug 14, 2025
pulisher
Aug 14, 2025

RSI + MACD Show Convergence for Voyager Therapeutics Inc.Capital Growth Entry Forecast Summary - beatles.ru

Aug 14, 2025
pulisher
Aug 13, 2025

A Quick Look at Today's Ratings for Voyager Therapeutics(VYGR.US), With a Forecast Between $8 to $18 - 富途牛牛

Aug 13, 2025
pulisher
Aug 13, 2025

Voyager Therapeutics Extends Cash Runway to 2028 - TipRanks

Aug 13, 2025
pulisher
Aug 12, 2025

Wedbush Lowers Voyager Therapeutics (NASDAQ:VYGR) Price Target to $8.00 - MarketBeat

Aug 12, 2025
pulisher
Aug 09, 2025

Truist Financial Keeps Their Buy Rating on Voyager Therapeutics (VYGR) - The Globe and Mail

Aug 09, 2025
pulisher
Aug 08, 2025

Voyager Therapeutics (VYGR) Reports Q2 Loss, Lags Revenue Estimates - MSN

Aug 08, 2025
pulisher
Aug 08, 2025

Voyager Therapeutics: Strategic Restructuring and Pipeline Progress Underpin Buy Rating - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

Voyager Therapeutics Inc. stock trend forecastStock Holding Strategy Long-Term Summary Sheet - Newser

Aug 08, 2025
pulisher
Aug 07, 2025

Voyager Therapeutics: Strong Financial Position and Promising Pipeline Drive Buy Rating - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Voyager Therapeutics: Wedbush Downgrades to Outperform, PT to $8 from $9 - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Voyager Therapeutics Q2 Earnings: A $33.4 Million SetbackNews and Statistics - IndexBox

Aug 07, 2025
pulisher
Aug 07, 2025

Voyager Therapeutics 2025 Q2 Earnings Deepened Losses Amid Extended Cash Runway - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Voyager Reports Second Quarter 2025 Financial and Operating Results - The Manila Times

Aug 07, 2025
pulisher
Aug 06, 2025

Voyager Therapeutics Inc earnings missed by $0.04, revenue fell short of estimates - Investing.com South Africa

Aug 06, 2025
pulisher
Aug 06, 2025

Voyager Therapeutics: Q2 Earnings Snapshot - News-Times

Aug 06, 2025
pulisher
Aug 06, 2025

Voyager Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2025
pulisher
Aug 06, 2025

Voyager Therapeutics Q2 collaboration revenue drops, extends cash runway to 2028 - TradingView

Aug 06, 2025
pulisher
Aug 06, 2025

Voyager Therapeutics Q2 2025 Financial and Operating Results - TradingView

Aug 06, 2025
pulisher
Aug 06, 2025

MarineMax (HZO) adds Odilon Almeida Jr.; two directors resign – 8-K | VYGR SEC FilingForm 8-K - Stock Titan

Aug 06, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Voyager Therapeutics Inc. stockBuild your wealth with consistent stock growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Voyager Therapeutics Inc. stock priceTurbocharged investment results - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Voyager Therapeutics Inc. stock overvalued or undervaluedFree Stock Index Interpretation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Voyager Therapeutics Inc. stockFree Real-Time Stock Data - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the technical indicators suggesting about Voyager Therapeutics Inc.Outstanding investment returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Voyager Therapeutics Inc. generate profit in a changing economyMarket-crushing stock picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Voyager Therapeutics Inc.Maximize portfolio value with smart investment plans - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What are Voyager Therapeutics Inc. company’s key revenue driversMaximize returns with effective portfolio management - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What catalysts could drive Voyager Therapeutics Inc. stock higher in 2025Achieve consistent profits with disciplined trading - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are analysts’ price targets for Voyager Therapeutics Inc. in the next 12 monthsHigh-impact investment strategies - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Should I hold or sell Voyager Therapeutics Inc. stock in 2025Consistent high-performance stocks - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What is the dividend policy of Voyager Therapeutics Inc. stockFree Stock Market Knowledge Sharing - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

How many analysts rate Voyager Therapeutics Inc. as a “Buy”Wealth Building Data Feed For Every Investor - jammulinksnews.com

Aug 01, 2025
pulisher
Jul 31, 2025

Is Voyager Therapeutics Inc. forming a bottoming baseStock Market Entry Timing Signals Revealed - metal.it

Jul 31, 2025
pulisher
Jul 31, 2025

How does Voyager Therapeutics Inc. compare to its industry peersExpert Picks Tracker From AI Tools - Jammu Links News

Jul 31, 2025
pulisher
Jul 30, 2025

Voyager Therapeutics Inc. Added to High Probability Setup ListBuy Signal Based on Chart Analysis Confirmed - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

Voyager Therapeutics Inc. Tests 50 Day MA After Sharp DeclineQuick Gain Stock Watch With Indicators Reviewed - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Why did Voyager's net profit surge in Q4 2024 despite high operating expenses? - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Pattern Scan Adds Voyager Therapeutics Inc. to WatchlistMarket Entry and Exit Point Tips From Traders - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 08:53:38 - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Is Voyager Therapeutics Inc. a growth stock or a value stockAI Powered Target Finder For Consistent Profits - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Top Risks to Consider Before Buying Voyager Therapeutics Inc. StockPortfolio Diversification Stock Ideas From Experts - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Voyager Therapeutics Inc. stockPost Market Review For 2025 - Jammu Links News

Jul 28, 2025

Voyager Therapeutics Inc Stock (VYGR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):